Form 4: Repare Therapeutics EVP, Chief Medical Officer Maria Koehler Sells Shares to Cover Tax Obligations

Maria Koehler, EVP and Chief Medical Officer of Repare Therapeutics, sold shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• Maria Koehler, the EVP and Chief Medical Officer of Repare Therapeutics, sold 500 common shares on March 28, 2024, at a weighted average price of $4.64.
• She also sold 300 common shares on April 1, 2024, at a weighted average price of $4.66.
• These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 22, 2023.
• The sales were to cover tax withholding obligations related to the vesting of 8,817 restricted stock units (RSUs) on January 30, 2024, which were part of a grant of 26,450 RSUs on January 30, 2023.
• Following these transactions, Koehler beneficially owns 231,409 common shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The share sales are related to tax obligations and were pre-planned, so they don't necessarily reflect a change in the executive's view of the company's prospects.

Positives

• The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating they were planned and not based on immediate market sentiment.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and are generally not indicative of a negative outlook on the company's future.

Stakeholder Impact

• The share sales may have a minor dilutive effect on existing shareholders.

Key Dates